CVS Health (CVS) Stock Forecast & Price Target $93.45 -0.73 (-0.77%) Closing price 05/20/2026 03:59 PM EasternExtended Trading$93.15 -0.30 (-0.32%) As of 05/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVS Health - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 26 Analyst RatingsSell0Hold4Buy22 Based on 26 Wall Street analysts who have issued ratings for CVS Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 26 analysts, 4 have given a hold rating, and 22 have given a buy rating for CVS. Consensus Price Target $98.685.59% Upside According to the 26 analysts' twelve-month price targets for CVS Health, the average price target is $98.68. The highest price target for CVS is $111.00, while the lowest price target for CVS is $72.00. The average price target represents a forecasted upside of 5.59% from the current price of $93.45. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CVS Health and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVS Analyst Ratings Over TimeTypeCurrent Forecast5/21/25 to 5/21/261 Month Ago4/21/25 to 4/21/263 Months Ago2/20/25 to 2/20/261 Year Ago5/21/24 to 5/21/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)1 Strong Buy rating(s)Buy22 Buy rating(s)20 Buy rating(s)19 Buy rating(s)14 Buy rating(s)Hold4 Hold rating(s)3 Hold rating(s)4 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$98.68$95.05$94.91$75.27Forecasted Upside5.59% Upside22.82% Upside23.84% Upside21.15% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy CVS Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CVS Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CVS Health Stock vs. The CompetitionTypeCVS HealthMedical CompaniesBroader MarketConsensus Rating Score 2.85 2.29 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside5.59% Upside1,726.27% Upside16.44% UpsideNews Sentiment RatingPositive NewsSee Recent CVS NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/20/2026 Mizuho4 of 5 starsAnn Hynes2 of 5 starsBoost TargetOutperform$102.00 ➝ $110.00+16.80%5/14/2026 Argus3 of 5 stars Boost TargetBuy$90.00 ➝ $104.00+5.84%5/14/2026 Morgan Stanley3 of 5 starsErin Wright4 of 5 starsBoost TargetOverweight$93.00 ➝ $106.00+7.87%5/12/2026 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLisa GillSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$101.00 ➝ $111.00+20.31%5/12/2026 Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLance WilkesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$94.00 ➝ $106.00+14.89%5/11/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCharles RhyeeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$105.00 ➝ $110.00+20.18%5/8/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingHold (C)5/8/2026 Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingStephen BaxterSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$102.00 ➝ $103.00+17.93%5/7/2026 Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBen HendrixSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$93.00 ➝ $107.00+23.53%5/7/2026 BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAndrew MokSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$93.00 ➝ $101.00+16.24% Get the Latest News and Ratings for CVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter. 5/7/2026 UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKevin CaliendoSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$97.00 ➝ $100.00+14.50%5/7/2026 Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid MacDonaldSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$98.00 ➝ $102.00+16.34%5/7/2026 DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$80.00 ➝ $100.00+14.05%5/7/2026 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$88.00 ➝ $92.00+4.93%5/5/2026 HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetHold$83.00 ➝ $85.00+3.39%4/15/2026 Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael HaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$92.00 ➝ $94.00+21.09%3/31/2026 Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJessica TassanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$101.00 ➝ $99.00+38.70%3/5/2026 Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael ChernySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform$98.00+23.58%3/2/2026 Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetOutperform$100.00 ➝ $97.00+20.86%2/12/2026 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingScott FidelSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$95.00 ➝ $97.00+23.39%1/27/2026 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael ChernySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$100.00 ➝ $95.00+26.58%12/10/2025 Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSarah JamesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOverweight10/31/2025 Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost Target$75.00 ➝ $90.00+15.20%10/30/2025 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost Target$92.00 ➝ $98.00+25.44%10/30/2025 EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingElizabeth AndersonSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$85.00 ➝ $95.00+22.55%9/8/2025 Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeStrong-Buy ➝ Hold7/16/2025 Bernstein BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetMarket Perform$78.00 ➝ $72.00+12.86%1/30/2025 Edward JonesSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:27 AM ET. Should I Buy CVS Health Stock? CVS Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, May 15, 2026. Please send any questions or comments about these CVS Health pros and cons to contact@marketbeat.com. CVS Health Bull Case Here are some ways that investors could benefit from investing in CVS Health Co.: CVS Health Co. recently reported a strong Q1 performance with adjusted earnings per share significantly exceeding estimates, indicating robust operational efficiency and profitability. The current stock price is around $87.70, which reflects a potential upside based on recent analyst target price increases, suggesting that the stock may be undervalued. Analysts have raised their price targets for CVS Health Co., with several maintaining a "buy" rating, indicating positive sentiment and confidence in the company's future growth. Improvements in Aetna’s medical benefit ratio have contributed to a substantial net income, showcasing the effectiveness of CVS Health Co.'s insurance segment and its impact on overall profitability. CVS Caremark's initiatives to expand biosimilar formulary adoption are expected to lower drug costs, which could enhance pharmacy margins and support long-term financial health. CVS Health Bear Case Investors should be bearish about investing in CVS Health Co. for these reasons: Despite recent positive developments, some analysts remain cautious, with a notable firm maintaining a "hold" rating and a price target below the current stock price, indicating limited near-term upside potential. The company's debt-to-equity ratio suggests a moderate level of debt, which could pose risks if not managed effectively, especially in a fluctuating economic environment. While recent earnings were strong, the overall market sentiment can shift quickly, and any negative news could impact stock performance significantly. CVS Health Co. operates in a highly competitive healthcare market, and any missteps in strategy or execution could adversely affect its market position and profitability. Regulatory changes in the healthcare sector could impact CVS Health Co.'s operations and profitability, introducing uncertainty for investors. CVS Forecast - Frequently Asked Questions What is CVS Health's forecast for 2026? According to the research reports of 26 Wall Street equities research analysts, the average twelve-month stock price forecast for CVS Health is $98.68, with a high forecast of $111.00 and a low forecast of $72.00. Should I buy or sell CVS Health stock right now? 26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings and 22 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CVS shares. Does CVS Health's stock price have much upside? According to analysts, CVS Health's stock has a predicted upside of 5.59% based on their 12-month stock forecasts. Has CVS Health been upgraded by Wall Street analysts recently? Over the previous 90 days, CVS Health's stock had 1 upgrade by analysts. What analysts cover CVS Health? CVS Health has been rated by research analysts at Argus, Barclays, DA Davidson, Deutsche Bank Aktiengesellschaft, HSBC, JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days. Do Wall Street analysts like CVS Health more than its competitors? Analysts like CVS Health more than other "medical" companies. The consensus rating for CVS Health is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CVS compares to other companies. Stock Forecasts and Research Tools Related Companies Amazon.com Stock Forecast Walmart Stock Forecast Cigna Group Stock Forecast Humana Stock Forecast UnitedHealth Group Stock Forecast Danaher Stock Forecast Elevance Health Stock Forecast Cencora Stock Forecast Natera Stock Forecast Labcorp Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With CVS Health RecommendationsMizuhoMorgan StanleyArgusSanford C. BernsteinJPMorgan Chase & Co.TD CowenWall Street ZenWeiss RatingsWells Fargo & CompanyUBS GroupTruist FinancialBarclaysRoyal Bank Of CanadaDeutsche Bank AktiengesellschaftDA Davidson This page (NYSE:CVS) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
